20240050439. 6-ARYL-4-MORPHOLIN-1-YLPYRIDONE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER AND DIABETES simplified abstract (Spring Bioscience AB)
Contents
6-ARYL-4-MORPHOLIN-1-YLPYRIDONE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER AND DIABETES
Organization Name
Inventor(s)
Jessica Martinsson of Huddinge (SE)
Martin Andersson of Huddinge (SE)
[[:Category:Johan Lindst�m of Huddinge (SE)|Johan Lindst�m of Huddinge (SE)]][[Category:Johan Lindst�m of Huddinge (SE)]]
Richard Forsblom of Huddinge (SE)
Tobias Ginman of Huddinge (SE)
Jenny Viklund of Huddinge (SE)
6-ARYL-4-MORPHOLIN-1-YLPYRIDONE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER AND DIABETES - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240050439 titled '6-ARYL-4-MORPHOLIN-1-YLPYRIDONE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER AND DIABETES
Simplified Explanation
The invention provides novel 6-aryl or 6-heteroaryl 4-morpholin-4-yl-pyhdine-2-one compounds of formula (i), pharmaceutical compositions containing such compounds, and methods for using such compounds in the treatment of diseases including cancer, diabetes, inflammatory diseases, neurodegenerative disorders, cardiovascular disorders, and viral infections. The compounds are defined by specific structural features and substitutions.
- The invention is about novel compounds of formula (i) and their use in treating various diseases.
- The compounds are 6-aryl or 6-heteroaryl 4-morpholin-4-yl-pyhdine-2-one compounds.
- The compounds have specific structural features and substitutions.
- Pharmaceutical compositions containing these compounds are also provided.
- The compounds can be used in the treatment of diseases such as cancer, diabetes, inflammatory diseases, neurodegenerative disorders, cardiovascular disorders, and viral infections.
- The invention includes methods for using these compounds in the treatment of the mentioned diseases.
Potential Applications
The potential applications of this technology include:
- Treatment of cancer
- Treatment of diabetes
- Treatment of inflammatory diseases
- Treatment of neurodegenerative disorders
- Treatment of cardiovascular disorders
- Treatment of viral infections
Problems Solved
This technology solves the following problems:
- Lack of effective treatments for cancer, diabetes, inflammatory diseases, neurodegenerative disorders, cardiovascular disorders, and viral infections
- Limited options for treating these diseases
- Need for novel compounds with specific structural features and substitutions
Benefits
The benefits of this technology are:
- Novel compounds with potential therapeutic effects
- Expanded treatment options for various diseases
- Potential improvement in patient outcomes
- Possibility of developing targeted therapies for specific diseases
Original Abstract Submitted
the invention provides novel 6-aryl or 6-heteroaryl 4-morpholin-4-yl-pyhdine-2-one compounds of formula (i), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, diabetes, inflammatory diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein r, r, a rand rare as defined in the specification.
